Straumann Holding AG

SWX:STMN Stock Report

Market Cap: CHF 18.9b

Straumann Holding Past Earnings Performance

Past criteria checks 1/6

Straumann Holding has been growing earnings at an average annual rate of 10.6%, while the Medical Equipment industry saw earnings growing at 10.6% annually. Revenues have been growing at an average rate of 12.7% per year. Straumann Holding's return on equity is 14.7%, and it has net margins of 11.3%.

Key information

10.6%

Earnings growth rate

10.5%

EPS growth rate

Medical Equipment Industry Growth11.1%
Revenue growth rate12.7%
Return on equity14.7%
Net Margin11.3%
Next Earnings Update19 Feb 2025

Recent past performance updates

Recent updates

Is Now The Time To Look At Buying Straumann Holding AG (VTX:STMN)?

Dec 16
Is Now The Time To Look At Buying Straumann Holding AG (VTX:STMN)?

Investors Shouldn't Overlook The Favourable Returns On Capital At Straumann Holding (VTX:STMN)

Oct 31
Investors Shouldn't Overlook The Favourable Returns On Capital At Straumann Holding (VTX:STMN)

Straumann Holding (VTX:STMN) Has A Pretty Healthy Balance Sheet

Oct 18
Straumann Holding (VTX:STMN) Has A Pretty Healthy Balance Sheet

Is Straumann Holding (VTX:STMN) A Risky Investment?

Jun 04
Is Straumann Holding (VTX:STMN) A Risky Investment?

Calculating The Fair Value Of Straumann Holding AG (VTX:STMN)

Apr 29
Calculating The Fair Value Of Straumann Holding AG (VTX:STMN)

Straumann Holding AG's (VTX:STMN) P/S Still Appears To Be Reasonable

Apr 15
Straumann Holding AG's (VTX:STMN) P/S Still Appears To Be Reasonable

Is Now The Time To Look At Buying Straumann Holding AG (VTX:STMN)?

Mar 18
Is Now The Time To Look At Buying Straumann Holding AG (VTX:STMN)?

Straumann Holding (VTX:STMN) Is Reinvesting At Lower Rates Of Return

Feb 29
Straumann Holding (VTX:STMN) Is Reinvesting At Lower Rates Of Return

Straumann Holding AG's (VTX:STMN) Popularity With Investors Is Clear

Jan 09
Straumann Holding AG's (VTX:STMN) Popularity With Investors Is Clear

Revenue & Expenses Breakdown

How Straumann Holding makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

SWX:STMN Revenue, expenses and earnings (CHF Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 242,5412881,2550
31 Mar 242,4772671,2290
31 Dec 232,4122461,2040
30 Sep 232,3133301,1550
30 Jun 232,2863941,1750
31 Mar 232,3044151,1940
31 Dec 222,3214351,2120
30 Sep 222,2684621,1570
30 Jun 222,2154891,1020
31 Mar 222,1184421,0530
31 Dec 212,0223961,0040
30 Sep 211,9143779290
30 Jun 211,8063588550
31 Mar 211,6162247930
31 Dec 201,426917310
30 Sep 201,424797410
30 Jun 201,421677510
31 Mar 201,5091877760
31 Dec 191,5963068010
30 Sep 191,5292987690
30 Jun 191,4622897370
31 Mar 191,4132817080
31 Dec 181,3642736800
30 Sep 181,3072716520
30 Jun 181,2502696240
31 Mar 181,1812745920
31 Dec 171,1122805610
30 Sep 171,0562575440
30 Jun 171,0002355280
31 Mar 179592325110
31 Dec 169182304940
30 Sep 168892184830
30 Jun 168612074730
31 Mar 168301394590
31 Dec 15799714450
30 Sep 15774794340
30 Jun 15750884230
31 Mar 157301234180
31 Dec 147101584130
30 Sep 146971374160
30 Jun 146841164180
31 Mar 146821094210
31 Dec 136801014240

Quality Earnings: STMN has a large one-off loss of CHF171.4M impacting its last 12 months of financial results to 30th June, 2024.

Growing Profit Margin: STMN's current net profit margins (11.3%) are lower than last year (17.3%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: STMN's earnings have grown by 10.6% per year over the past 5 years.

Accelerating Growth: STMN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: STMN had negative earnings growth (-27%) over the past year, making it difficult to compare to the Medical Equipment industry average (-1.6%).

Return on Equity

High ROE: STMN's Return on Equity (14.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 06:06
End of Day Share Price 2024/12/18 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Straumann Holding AG is covered by 47 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hassan Al-WakeelBarclays
Robert BateBarclays
Beatrice FairbairnBerenberg